R Financial Services Filed Oct 14
Sold $1K–$15K on Aug 31, 2026 · spouse account
Amount$15Kband top
Trade price$220.78Aug 31
Realized P&L No buy on record price down 7.3% since sale
Filing gap44dwithin 45d
Daniel Meuser (R-PA), U.S. Representative, has disclosed 8 trades since 2026: 1 purchase and 7 sales. 7 are listed stocks; the other 1 is another asset. The latest disclosed trade is a sale of NVDA on Aug 31, 2026. Most-traded: NVDA. Recent share trades (last 12 months) average -3.6% since the trade date, 43% of them in profit.
| Committee | Role |
|---|---|
| House Committee on Financial Services | Member |
| House Committee on Small Business | Member |
| Contracting and Infrastructure | Member |
| Economic Growth, Tax, and Capital Access | Member |
| Oversight and Investigations | Chair |
| Financial Institutions | Member |
| Bill | Companies lobbying | Introduced | Status |
|---|---|---|---|
| Most Favored Patient Act of 2026 | AMGNAmgen PFEPfizer GSKGSK BEAMBeam Therapeutics | Mar 5, 2026 | committee |
| SCAM Act | JPMJPMorgan Chase WFCWells Fargo BACBank of America TFCTruist Financial HBANHuntington Bancshares | Feb 12, 2026 | committee |
Portrait: Image courtesy of the Member, via Congress.gov.